Skip to Content
MilliporeSigma
All Photos(1)

Documents

EMU157701

Sigma-Aldrich

MISSION® esiRNA

targeting mouse Id4

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

TCAGCAAATCTAGAAACGTCGTCTCGTCTTGTCATTCCAAGAGAGAGAGAGAGAGAGAGAGAGAAGGGGAAAAATAAAACTTAAATTCACTTTTACTTTTTTTGCACGTTCACGAGCATTCACCGTACGTATTCTCTTTCGTTTCTTCTTTTATGACCGCTGTGAATTGTACGTTTCTGTGGTTATTTTTATCACCCTTTTGAAGGTGCAGTTAAACTTCGAAGCTTAAGTGTTGTCGACCAGACTGCTAAGTAGAAGAGCAATCGTGAATCCAACCTTAGAGGCTACATTGTGACAAGGGAACTGTTTTTGTTTTTGAAGCTTTACTAATATACCAGAGCACTGTAGATATGTTGTTTTACATCTATTGTTTAAAATAGATGATTATAACAGGGCGGGGAACTTTTTCTCTGCAAGAATGTTACATATTGTATAGATAAGTGAGTGACATTTCATACCCTGTATATATAGAGATGTTCTATAAGTGTGAGAAAGTATATGCGCTTTAAT

Ensembl | mouse accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Se-Jin Park et al.
Laboratory animal research, 27(4), 333-338 (2012-01-11)
The cancer stem cell (CSC) hypothesis proposes that CSCs are the root of cancer. CSC-targeted therapies may prevent cancer relapse and provide more effective treatment. The expression of aldehyde dehydrogenase 1, as assessed by the Aldefluor assay, has been recognized
Simon Junankar et al.
Nature communications, 6, 6548-6548 (2015-03-31)
Basal-like breast cancer (BLBC) is a heterogeneous disease with poor prognosis; however, its cellular origins and aetiology are poorly understood. In this study, we show that inhibitor of differentiation 4 (ID4) is a key regulator of mammary stem cell self-renewal

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service